These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 25196898

  • 1. Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor.
    Yoshida M, Hazekawa M, Haraguchi T, Uchida T.
    Drug Dev Ind Pharm; 2015; 41(8):1387-92. PubMed ID: 25196898
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T, Yoshida M, Hazekawa M, Haraguchi T, Furuno H, Teraoka M, Ikezaki H.
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [Abstract] [Full Text] [Related]

  • 3. Famotidine orally disintegrating tablets: bitterness comparison of original and generic products.
    Tokuyama E, Matsunaga C, Yoshida K, Mifsud JC, Irie T, Yoshida M, Uchida T.
    Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):382-7. PubMed ID: 19336932
    [Abstract] [Full Text] [Related]

  • 4. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus.
    Harada T, Uchida T, Yoshida M, Kobayashi Y, Narazaki R, Ohwaki T.
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1009-14. PubMed ID: 20686251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
    Sotoyama M, Uchida S, Tanaka S, Hakamata A, Odagiri K, Inui N, Watanabe H, Namiki N.
    Biol Pharm Bull; 2017 Aug; 40(4):451-457. PubMed ID: 28381800
    [Abstract] [Full Text] [Related]

  • 7. The quantitative prediction of bitterness-suppressing effect of sweeteners on the bitterness of famotidine by sweetness-responsive sensor.
    Hashimoto Y, Matsunaga C, Tokuyama E, Tsuji E, Uchida T, Okada H.
    Chem Pharm Bull (Tokyo); 2007 May; 55(5):739-46. PubMed ID: 17473460
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI, Cho SM, Cui JH, Cao QR, Oh E, Lee BJ.
    Int J Pharm; 2013 Oct 15; 455(1-2):31-9. PubMed ID: 23933050
    [Abstract] [Full Text] [Related]

  • 9. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.
    Sugiura T, Uchida S, Namiki N.
    Chem Pharm Bull (Tokyo); 2012 Oct 15; 60(3):315-9. PubMed ID: 22382410
    [Abstract] [Full Text] [Related]

  • 10. [Comprehensive evaluation of palatability for commercial medicine by taste sensing system].
    Uchida T.
    Yakugaku Zasshi; 2014 Oct 15; 134(3):317-23. PubMed ID: 24584008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.
    Takano H, Uchida S, Kashiwagura Y, Tanaka S, Hakamata A, Odagiri K, Inui N, Watanabe H, Namiki N.
    Chem Pharm Bull (Tokyo); 2019 Oct 15; 67(2):112-119. PubMed ID: 30713270
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factors affecting the bitterness intensities of ten commercial formulations of ambroxol.
    Uchida T, Sugino Y, Hazekawa M, Yoshida M, Haraguchi T.
    Chem Pharm Bull (Tokyo); 2012 Oct 15; 60(8):949-54. PubMed ID: 22863696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Taste masking microspheres for orally disintegrating tablets.
    Xu J, Bovet LL, Zhao K.
    Int J Pharm; 2008 Jul 09; 359(1-2):63-9. PubMed ID: 18455893
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
    Lou H, Liu M, Qu W, Hu Z, Brunson E, Johnson J, Almoazen H.
    Drug Dev Ind Pharm; 2014 Jul 09; 40(7):910-8. PubMed ID: 23621768
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.